Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

Clinical trial NCT06198296 · RECRUITING

Trial details

NCT number: NCT06198296
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatoblastoma Hepatocellular Carcinoma Wilms Tumor Malignant Rhabdoid Tumor Yolk Sac Tumor Rhabdomyosarcoma Liposarcoma Embryonal Sarcoma of Liver

Start date: 2025-06-10
Primary completion: 2028-02-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.